Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson's disease in diabetic patients.

Sci Rep · 2023 · PMC10728170 · PMID 38110464

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Vildagliptin was significantly correlated with a lower risk of PD (aHR 0.46; 95% CI 0.27–0.77), while sitagliptin and linagliptin only showed a trend.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.